KBC Group’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$116K Hold
5,602
﹤0.01% 1240
2025
Q4
$182K Hold
5,602
﹤0.01% 950
2025
Q3
$318K Buy
5,602
+661
+13% +$33.9K ﹤0.01% 765
2025
Q2
$246K Sell
4,941
-3,487
-41% -$158K ﹤0.01% 798
2025
Q1
$249K Sell
8,428
-43
-0.5% -$1.6K ﹤0.01% 949
2024
Q4
$205K Buy
8,471
+4,396
+108% +$109K ﹤0.01% 1116
2024
Q3
$75K Hold
4,075
﹤0.01% 1477
2024
Q2
$82K Buy
+4,075
New +$67.8K ﹤0.01% 1291

Other funds holding HIMS

KBC Group's HIMS Position: Q1 2026 in Review

KBC Group held its Hims & Hers Health (HIMS) position steady in Q1 2026 at 5,602 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

KBC Group first reported a position in HIMS in Q2 2024 and has held it in 8 quarters since. The position peaked at $318K in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • KBC Group held 5,602 shares of Hims & Hers Health worth $116K as of Q1 2026.
  • KBC Group left its Hims & Hers Health share count unchanged in Q1 2026.
  • Hims & Hers Health made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1240 holding.
  • KBC Group first reported a position in Hims & Hers Health in Q2 2024 and has held it in 8 quarters since.
  • KBC Group's Hims & Hers Health position peaked at $318K in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.